Role of endothelin receptor A and NADPH oxidase in vascular abnormalities

References

• SuWDaiDZLiuHRNaTDaiYUpregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus CorniClin Exp Pharmacol Physiol200734121228123317973859
   PubMed Web of Science ®Google Scholar
• DobarroDGómez-RubínMCSanchez-RecaldeACurrent pharmacological approach to restore endothelial dysfunctionCardiovasc Hematol Agents Med Chem20097321222219689260
   PubMedGoogle Scholar
• ShahREndothelins in health and diseaseEur J Intern Med200718427228217574100
   PubMed Web of Science ®Google Scholar
• RomeroMJiménezRSánchezMQuercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKCAtherosclerosis20092021586718436224
   PubMed Web of Science ®Google Scholar
• LiuHRTangXYDaiDZDaiYEthanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in ratsJ Ethnopharmacol2008118346647218585879
   PubMed Web of Science ®Google Scholar
• DaiDZThe antiarrhythmic activity of protoberberines in relation to blockade of ion channelsIon Channel Modulators ID Research Alert19972383390
   Google Scholar
• DaiDZCPU86017: a novel Class III antiarrhythmic agent with multiple actions at ion channelsCardiovasc Drug Rev200624210111516961724
   PubMedGoogle Scholar
• ZhangTTCuiBDaiDZTangXYPharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats: mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathwayJ Cardiovasc Pharmacol200546672773416306794
   PubMed Web of Science ®Google Scholar
• ZhangTTCuiBDaiDZSuWCPU 86017, p-chlorobenzyltetrahy-droberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathwayActa Pharmacol Sin200526111309131616225752
   PubMed Web of Science ®Google Scholar
• NaTHuangZJDaiDZZhangYDaiYAbrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017Acta Pharmacol Sin200728677378217506935
   PubMed Web of Science ®Google Scholar
• QiMYFengYDaiDZLiNChengYSDaiYCPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activityActa Pharmacol Sin201031216517420139899
   PubMed Web of Science ®Google Scholar
• LiNDaiDZDaiYCPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulationNaunyn Schmiedebergs Arch Pharmacol2008378554155218548232
   PubMed Web of Science ®Google Scholar
• CuiBChengYSDaiDZLiNZhangTTDaiYCPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in ratsClin Exp Pharmacol Physiol200936216917518986320
   PubMed Web of Science ®Google Scholar
• YuTSheuSSRobothamJLYoonYMitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen speciesCardiovasc Res200879234135118440987
   PubMed Web of Science ®Google Scholar
• Fatehi-HassanabadZChanCBFurmanBLReactive oxygen species and endothelial function in diabetesEur J Pharmacol20106361–381720371238
   PubMed Web of Science ®Google Scholar
• XuJLiNDaiDZYuFDaiYThe endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase, ETA ETB, and MMP9 in the vasculatureJ Cardiovasc Pharmacol2008521424818594475
   PubMed Web of Science ®Google Scholar
• LassegueBClempusREVascular NAD(P)H oxidases: specific features, expression, and regulationAm J Physiol Regul Integr Comp Physiol2003285R277R29712855411
   PubMed Web of Science ®Google Scholar
• LiNJiaNDaiDZDaiYEndothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKC epsilonEur J Pharmacol20085911–321121818611397
   PubMed Web of Science ®Google Scholar
• CottoneSMulèGGuarneriMEndothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patientsNephrol Dial Transplant200924249750318772174
   PubMed Web of Science ®Google Scholar
• Bruce-KellerAJGuptaSParrinoTENOX activity is increased in mild cognitive impairmentAntioxid Redox Signal201012121371138219929442
   PubMed Web of Science ®Google Scholar
• XuMDaiDZZhangQChengYSDaiYUpregulated NADPH oxidase contributes to diabetic testicular complication and is relieved by strontium fructose 1,6-diphosphateExp Clin Endocrinol Diabetes2010118745946520200810
   PubMed Web of Science ®Google Scholar
• TangXYLiuQDaiDZDaiYCPU0213, a novel endothelin receptor antagonist, suppresses the upregulation of matrix metalloproteinases and connexin 43 in hyperthyroid myocardiumPharmacol Rep200860452453118799821
   PubMed Web of Science ®Google Scholar
• ShenGXOxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidaseCan J Physiol Pharmacol201088324124820393589
   PubMed Web of Science ®Google Scholar
• QiMYXiaHJDaiDZDaiYA novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in ratsJ Cardiovasc Pharmacol200647672973516810072
   PubMed Web of Science ®Google Scholar
• QiMYLiuHRDaiDZLiNDaiYTotal triterpene acids, active ingredients from Fructus Corni, attenuate diabetic cardiomyopathy by normalizing ET pathway and expression of FKBP12.6 and SERCA2a in streptozotocin-ratsJ Pharm Pharmacol200860121687169419000375
   PubMed Web of Science ®Google Scholar
• ZhangQLiuHRYingHJDaiDZTangXYDaiYStrontium fructose 1,6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated ratsJ Pharm Pharmacol200961222923619178771
   PubMed Web of Science ®Google Scholar
• MatsuoJOkuHKanbaraYKobayashiTSugiyamaTIkedaTInvolvement of NADPH oxidase and protein kinase C in endothelin-1-induced superoxide production in retinal microvesselsExp Eye Res200989569369919576886
   PubMed Web of Science ®Google Scholar
• ZengQZhouQYaoFO’RourkeSTSunCEndothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxideJ Pharmacol Exp Ther2008326373273818539650
   PubMed Web of Science ®Google Scholar
• DuanJXuHDaiSPhytoestrogen alpha-zearalanol inhibits homocysteine-induced endothelin-1 expression and oxidative stress in human umbilical vein endothelial cellsAtherosclerosis2008197254955517900592
   PubMed Web of Science ®Google Scholar
• HongEHLeeSJKimJSIonizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinaseJ Biol Chem201028521283129519887452
   PubMed Web of Science ®Google Scholar
• DeedwaniaPSrikanthSDiabetes and vascular diseaseExpert Rev Cardiovasc Ther20086112713818095912
   PubMedGoogle Scholar
• PotenzaMAGagliardiSNacciCCarratu’MRMontagnaniMEndothelial dysfunction in diabetes: from mechanisms to therapeutic targetsCurr Med Chem20091619411219149564
   PubMed Web of Science ®Google Scholar
• Chronic renal disease, Chapter 3, Disease of kidney and Urinary systemTierneyLMMcPheeSJPapadakisMACurrent Medical Diagnosis and TreatmentMcGraw Hill/The People Health PublicationBeijing, China2002283290
   Google Scholar
• NeuhoferWPittrowDRole of endothelin and endothelin receptor antagonists in renal diseaseEur J Clin Invest200636788816919017
   PubMed Web of Science ®Google Scholar
• DrzewoskiJKasznickiJTrojanowskiZThe role of “metabolic memory” in the natural history of diabetes mellitusPol Arch Med Wewn20091197–849350019776690
   PubMed Web of Science ®Google Scholar
• MatsumotoTKobayashiTKamataKRelationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animalsJ Smooth Muscle Res2008442415518552452
   PubMedGoogle Scholar
• HamedSAHamedEAEzz EldinAMMahmoudNMVascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosisJ Stroke Cerebrovasc Dis20101929210320189084
   PubMed Web of Science ®Google Scholar
• KalogeropoulouKMortzosGMigdalisICarotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclinAngiology200253327928512025915
   PubMed Web of Science ®Google Scholar
• TzemosNLimPOMacDonaldTMValsartan improves endothelial dysfunction in hypertension: a randomized, double-blind studyCardiovasc Ther200927315115819604249
   PubMed Web of Science ®Google Scholar
• HirookaYKimuraYSagaraYItoKSunagawaKEffects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertensionClin Exp Hypertens200830326727618425706
   PubMed Web of Science ®Google Scholar
• YamanariHNakamuraKMiuraDYamanariSOheTSpironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stressClin Exp Hypertens200931758559419886856
   PubMed Web of Science ®Google Scholar
• KuklinskaAMMroczkoBMusialWJDiagnostic biomarkers of essential arterial hypertension: the value of prostacyclin, nitric oxide, oxidized-LDL, and peroxide measurementsInt Heart J200950334135119506338
   PubMed Web of Science ®Google Scholar
• KagotaSTadaYKubotaYPeroxynitrite is involved in the dysfunction of vasorelaxation in SHR/NDmcr-cp rats, spontaneously hypertensive obese ratsJ Cardiovasc Pharmacol200750667768518091585
   PubMed Web of Science ®Google Scholar
• NohriaAGarrettLJohnsonWKinlaySGanzPCreagerMAEndothelin-1 and vascular tone in subjects with atherogenic risk factorsHypertension2003421434812756218
   PubMed Web of Science ®Google Scholar
• LuoLDaiDZDaiYEffect of the endothelin receptor antagonist CPU0213, and its modulation by rifampin, on cardiac and vascular tissue following chronic isoproterenol treatmentClin Exp Pharmacol Physiol200835775776518215179
   PubMed Web of Science ®Google Scholar
• NguyenAThorin-TrescasesNThorinEWorking under pressure: coronary arteries and the endothelin systemAm J Physiol Regul Integr Comp Physiol2010317 [Epub ahead of print]
   Web of Science ®Google Scholar
• GalettaFFranzoniFVirdisAEndothelium-dependent vasodilation and carotid artery wall remodeling in athletes and sedentary subjectsAtherosclerosis2006186118419216102774
   PubMed Web of Science ®Google Scholar
• DjuricDPopovicZPetrovicJBojicMAge-related progressive brachial artery endothelial dysfunction precedes the changed carotid and left ventricular geometry in healthy humansAngiology199950755556110431995
   PubMed Web of Science ®Google Scholar
• BigorniaSJMottMMHessDTLong-term successful weight loss improves vascular endothelial function in severely obese individualsObesity (Silver Spring)201018475475920057371
   PubMed Web of Science ®Google Scholar
• YangXZLiuYMiJTangCSDUJBPre-clinical atherosclerosis evaluated by carotid artery intima-media thickness and the risk factors in childrenChin Med J (Engl)2007120535936217376303
   PubMed Web of Science ®Google Scholar
• WittekoekMEde GrootEPrinsMHTripMDBüllerHRKasteleinJJDifferences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular diseaseAtherosclerosis1999146227127910532683
   PubMed Web of Science ®Google Scholar
• LittlePJIveyMEOsmanNEndothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosisCurr Vasc Pharmacol20086319520318673159
   PubMed Web of Science ®Google Scholar
• Vladimirova-KitovaLGManukovIHSirakovaIDenevaTIEvaluation of the relationship between flow-mediated vasodilation and some atherogenic risk markers in severe hypercholesterolemiaFolia Med (Plovdiv)2008501222818543784
   PubMedGoogle Scholar
• XiaWFengWGuanMYuYLiJQuXIncreased levels of asymmetric dimethylarginine and C-reactive protein are associated with impaired vascular reactivity in essential hypertensionClin Exp Hypertens2010321434820144072
   PubMed Web of Science ®Google Scholar
• RodionovRNDayoubHLynchCMOverexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemiaCirc Res2010106355155820019334
   PubMed Web of Science ®Google Scholar
• LindLLarssonATeerlinkTL-Arginine is related to endothelium-dependent vasodilation in resistance and conduit arteries in divergent ways The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) studyAtherosclerosis2009203254454918757055
   PubMed Web of Science ®Google Scholar
• GatesPEBoucherMLSilverAEMonahanKDSealsDRImpaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expressionJ Appl Physiol20071021637116946027
   PubMed Web of Science ®Google Scholar
• IwamotoHYokoyamaAKitaharaYAirflow limitation in smokers is associated with subclinical atherosclerosisAm J Respir Crit Care Med20091791354018931335
   PubMed Web of Science ®Google Scholar
• ZhengLLiJHuDAssociation of low ankle-brachial index with mortality in patients with ischemic heart diseaseJ Atheroscler Thromb2010313 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• PurroyFCollBOróMPredictive value of ankle brachial index in patients with acute ischaemic strokeEur J Neurol20091124 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• TopakianRNanzSRohrbacherBKoppensteinerRAichnerFTfor the OECROSS Study GroupHigh prevalence of peripheral arterial disease in patients with acute ischaemic strokeCerebrovasc Dis201029324825420029198
   PubMed Web of Science ®Google Scholar
• OksalaNKViljamaaJSaimanenEVenermoMfor the ATTAC study groupModified ankle-brachial index detects more patients at risk in a Finnish primary health careEur J Vasc Endovasc Surg201039222723319969474
   PubMed Web of Science ®Google Scholar
• SuominenVUurtoISaarinenJVenermoMSaleniusJPAD as a risk factor for mortality among patients with elevated ABI – a clinical studyEur J Vasc Endovasc Surg201039331632220089422
   PubMed Web of Science ®Google Scholar
• FowkesFGPriceJFStewartMCAspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trialJAMA2010303984184820197530
   PubMed Web of Science ®Google Scholar
• Al-WakeelJSHammadDAl SuwaidaAMitwalliAHMemonNASulimaniFMicrovascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinicSaudi J Kidney Dis Transpl2009201778519112222
   PubMedGoogle Scholar
• AnSJBoydRZhuMChapmanAPimentelDRWangHDNADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblastsCardiovasc Res200775470270917391658
   PubMed Web of Science ®Google Scholar
• De GiustiVCCorreaMVVilla-AbrilleMCThe positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen speciesLife Sci2008837–826427118625248
   PubMed Web of Science ®Google Scholar
• YamaguchiOKaneshiroTSaitohSIshibashiTMaruyamaYTakeishiYRegulation of coronary vascular tone via redox modulation in the alpha1-adrenergic-angiotensin-endothelin axis of the myocardiumAm J Physiol Heart Circ Physiol20092961H226H23219028798
   PubMed Web of Science ®Google Scholar
• IsakaMKudoAImamuraMKawakamiHYasudaKEndothelin receptors, localized in sympathetic nerve terminals of the heart, modulate norepinephrine release and reperfusion arrhythmiasBasic Res Cardiol2007102215416216944358
   PubMed Web of Science ®Google Scholar
• PengHJDaiDZJiHDaiYThe separate roles of endothelin receptors participate in remodeling of matrix metalloproteinase and connexin 43 of cardiac fibroblasts in maladaptive response to isoproterenolEur J Pharmacol20106341–310110620167215
   PubMed Web of Science ®Google Scholar